tiprankstipranks
Kane Biotech Inc (TSE:KNE)
:KNE
Canadian Market
KNE
Kane Biotech
RESEARCH TOOLSreports
Want to see TSE:KNE full AI Analyst Report?

Kane Biotech (KNE) Income Statement

1 Followers

Kane Biotech Income Statement

Last quarter (Q4 2025), Kane Biotech's total revenue was C$-21.14K, a decrease of -105.12% from the same quarter last year. In Q4, Kane Biotech's net income was C$-546.86K. See Kane Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Mar 23Dec 21
Total Revenue
C$ 427.87KC$ 2.08MC$ 148.98KC$ 156.73KC$ 1.61M
Gross Profit
C$ -163.38KC$ 872.10KC$ 109.47KC$ 1.41MC$ 568.44K
Operating Expenses
C$ 2.95MC$ 4.80MC$ 3.47MC$ 4.78MC$ 5.45M
Depreciation and Amortization
C$ 162.74KC$ 218.47KC$ 116.05KC$ 257.68KC$ 187.97K
EBITDA
C$ -2.95MC$ -3.71MC$ -3.23MC$ -2.95MC$ -4.25M
Operating Income
C$ -3.11MC$ -4.49MC$ -3.36MC$ -3.46MC$ -4.88M
Other Income/Expenses
C$ 283.08KC$ 22.60KC$ -1.20MC$ -564.03KC$ 33.65K
Pretax Income
C$ -2.83MC$ -4.47MC$ -4.56MC$ -4.02MC$ -4.85M
Net Income
C$ -2.72MC$ -3.02MC$ -5.03MC$ -3.89MC$ -4.60M
Per Share Metrics
Basic EPS
C$ -0.02C$ -0.02C$ -0.04C$ -0.03C$ -0.04
Diluted EPS
C$ -0.02C$ -0.02C$ -0.04C$ -0.03C$ -0.04
Weighted Average Shares Outstanding
 162.22M 133.91M 140.26M 120.70M 112.60M
Weighted Average Shares Outstanding (Diluted)
 162.22M 133.91M 127.12M 120.70M 112.60M
Currency in CAD

Kane Biotech Earnings and Revenue History